FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a conjugate target - compound chosen from the following group: 
and 
wherein 
means a target; each among R and R' means independently unsubstituted (C1-C20)-aliphatic group, substituted (C1-C20)-aliphatic group, unsubstituted aryl or substituted aryl wherein aryl is a radical chosen from the group comprising phenyl, naphthyl, tetrahydronaphthyl, indanyl, indenyl, pyridyl, pyrazinyl, pyrimidinyl, pyrrolyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, isooxazolyl, thiadiazolyl, oxadiazolyl, thiophenyl, furanyl, quinolinyl, isoquinolinyl; m = 0, 1 or 2; n = 1 or 2. Also, invention describes library of compounds, method for identifying compounds, method for identifying the potential ligand. Proposed invention can promote to discovery of medicinal preparations.
EFFECT: valuable method for finding ligands.
20 cl, 8 dwg, 4 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY-DRUG CONJUGATE HAVING AN ACID SELF-STABILIZING BINDING SITE | 2018 |
|
RU2793125C2 |
| ANTIBODIES AND THEIR CONJUGATES | 2016 |
|
RU2744860C2 |
| CHEMICAL LINKERS AND CONJUGATES THEREOF | 2005 |
|
RU2402548C2 |
| MODULATION OF STRUCTURED PROTEINS SPECIFICITY | 2012 |
|
RU2631931C2 |
| KOVALENT-RELATED CONJUATES OF ANTIGEN-ANTIBODY | 2013 |
|
RU2684595C2 |
| MONOMETHYLVALINE COMPOUNDS CAPABLE OF FORMING CONJUGATES WITH LIGANDS | 2004 |
|
RU2448117C2 |
| BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | 2015 |
|
RU2708459C2 |
| BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
| BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | 2015 |
|
RU2824959C2 |
| SEZ6 ANTIBODY-DRUG CONJUGATE AND METHODS FOR APPLICATION | 2019 |
|
RU2770474C1 |
